Case report Fatal thrombosis with activated factor VII in a paediatric patient on extracorporeal membrane oxygenation
暂无分享,去创建一个
[1] P. Innerhofer,et al. Administration of Recombinant Activated Factor VII (NovoSeven) in Three Cases of Uncontrolled Bleeding Caused by Disseminated Intravascular Coagulopathy , 2007, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
[2] J. Dunning,et al. Is recombinant activated factor VII useful for intractable bleeding after cardiac surgery? , 2006, Interactive cardiovascular and thoracic surgery.
[3] A. Goldman,et al. Recombinant factor VII for severe bleeding during extracorporeal membrane oxygenation following open heart surgery , 2005, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[4] S. Friess,et al. Use of recombinant factor VIIa for refractory hemorrhage during extracorporeal membrane oxygenation* , 2005, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.
[5] H. Büller,et al. Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: A systematic review , 2005, Critical care medicine.
[6] N. Key,et al. Activated recombinant factor VII in cardiac surgery , 2005, Current opinion in anaesthesiology.
[7] Dougald M Monroe,et al. Safety profile of recombinant factor VIIa. , 2004, Seminars in hematology.
[8] M. Al Douri,et al. Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven®) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery , 2000, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.